DBL Irinotecan Injection Concentrate 20mg/ml
Product details
Registration number: SIN13367P
Classification: Prescription Only
Active ingredients: Irinotecan hydrochloride trihydrate
Strength: 20mg/mL
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Route: INTRAVENOUS
Registrant: PFIZER PRIVATE LIMITED
ATC code: L01XX19
HSA approval date: 26 October 2007
Manufacturer(s): Zydus Hospira Oncology Private Limited
Manufacturing country/countries: INDIA
What are the HSA registration number and classification for DBL Irinotecan Injection Concentrate 20mg/ml?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN13367P
Classification: Prescription Only
What active ingredients and strength are recorded for DBL Irinotecan Injection Concentrate 20mg/ml?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Irinotecan hydrochloride trihydrate
Strength: 20mg/mL
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for DBL Irinotecan Injection Concentrate 20mg/ml?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Route: INTRAVENOUS
Who is the recorded registrant for DBL Irinotecan Injection Concentrate 20mg/ml?
According to the HSA dataset updated 7 August 2026:
Registrant: PFIZER PRIVATE LIMITED
Which manufacturers and countries are listed for DBL Irinotecan Injection Concentrate 20mg/ml?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Zydus Hospira Oncology Private Limited
Manufacturing country/countries: INDIA
Where can I look up DBL Irinotecan Injection Concentrate 20mg/ml in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN13367P or the exact product name DBL Irinotecan Injection Concentrate 20mg/ml. The general register link does not preselect this product.
What are the source dates for this DBL Irinotecan Injection Concentrate 20mg/ml record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this DBL Irinotecan Injection Concentrate 20mg/ml record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN13367P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)